In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate

Frances L. Clouse; Laurie B. Hovde; John C Rotschafer

doi:10.1128/AAC.00435-07

In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate

Frances L. Clouse
, Laurie B. Hovde
, John C Rotschafer

Experimental and Clinical Pharmacology

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

This study compared the ability of telavancin to the ability of cefazolin and vancomycin to eliminate staphylococci from peritoneal dialysis fluid by using a static in vitro model to simulate the conditions of peritoneal dialysis. The results showed that telavancin exhibited statistically significantly better kill (P < 0.05) against both methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Original language	English (US)
Pages (from-to)	4521-4524
Number of pages	4
Journal	Antimicrobial agents and chemotherapy
Volume	51
Issue number	12
DOIs	https://doi.org/10.1128/AAC.00435-07
State	Published - Dec 2007

Publisher link

10.1128/AAC.00435-07

Find It

Find It at U of M Libraries

Cite this

In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate. / Clouse, Frances L.; Hovde, Laurie B.; Rotschafer, John C.
In: Antimicrobial agents and chemotherapy, Vol. 51, No. 12, 12.2007, p. 4521-4524.

Research output: Contribution to journal › Article › peer-review

@article{6295ee02c0b54dbb97a4f8fbc5f9735d,

title = "In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate",

abstract = "This study compared the ability of telavancin to the ability of cefazolin and vancomycin to eliminate staphylococci from peritoneal dialysis fluid by using a static in vitro model to simulate the conditions of peritoneal dialysis. The results showed that telavancin exhibited statistically significantly better kill (P < 0.05) against both methicillin-susceptible and methicillin-resistant Staphylococcus aureus.",

author = "Clouse, \{Frances L.\} and Hovde, \{Laurie B.\} and Rotschafer, \{John C\}",

year = "2007",

month = dec,

doi = "10.1128/AAC.00435-07",

language = "English (US)",

volume = "51",

pages = "4521--4524",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "12",

}

TY - JOUR

T1 - In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate

AU - Clouse, Frances L.

AU - Hovde, Laurie B.

AU - Rotschafer, John C

PY - 2007/12

Y1 - 2007/12

N2 - This study compared the ability of telavancin to the ability of cefazolin and vancomycin to eliminate staphylococci from peritoneal dialysis fluid by using a static in vitro model to simulate the conditions of peritoneal dialysis. The results showed that telavancin exhibited statistically significantly better kill (P < 0.05) against both methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

AB - This study compared the ability of telavancin to the ability of cefazolin and vancomycin to eliminate staphylococci from peritoneal dialysis fluid by using a static in vitro model to simulate the conditions of peritoneal dialysis. The results showed that telavancin exhibited statistically significantly better kill (P < 0.05) against both methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

UR - https://www.scopus.com/pages/publications/36749083961

UR - https://www.scopus.com/pages/publications/36749083961#tab=citedBy

U2 - 10.1128/AAC.00435-07

DO - 10.1128/AAC.00435-07

M3 - Article

C2 - 17908947

AN - SCOPUS:36749083961

SN - 0066-4804

VL - 51

SP - 4521

EP - 4524

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 12

ER -

In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate

Abstract

Publisher link

Find It

Other files and links

Fingerprint

Cite this